Canada markets closed

Edwards Lifesciences Corporation (EW)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
89.08+1.08 (+1.23%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 555.41B
Enterprise Value 354.89B
Trailing P/E 68.52
Forward P/E 135.92
PEG Ratio (5 yr expected) 12.84
Price/Sales (ttm)12.63
Price/Book (mrq)12.16
Enterprise Value/Revenue 312.51
Enterprise Value/EBITDA 738.56

Trading Information

Stock Price History

Beta (5Y Monthly) 1.04
52-Week Change 318.90%
S&P500 52-Week Change 348.25%
52 Week High 392.08
52 Week Low 366.23
50-Day Moving Average 383.16
200-Day Moving Average 383.87

Share Statistics

Avg Vol (3 month) 32.73M
Avg Vol (10 day) 32.91M
Shares Outstanding 5622.04M
Implied Shares Outstanding 6N/A
Float 619.33M
% Held by Insiders 10.73%
% Held by Institutions 185.93%
Shares Short (Mar. 30, 2021) 45.28M
Short Ratio (Mar. 30, 2021) 41.94
Short % of Float (Mar. 30, 2021) 40.86%
Short % of Shares Outstanding (Mar. 30, 2021) 40.85%
Shares Short (prior month Feb. 25, 2021) 45.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 23:1
Last Split Date 3May 31, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin 18.77%
Operating Margin (ttm)30.01%

Management Effectiveness

Return on Assets (ttm)11.99%
Return on Equity (ttm)18.88%

Income Statement

Revenue (ttm)4.39B
Revenue Per Share (ttm)7.05
Quarterly Revenue Growth (yoy)1.50%
Gross Profit (ttm)3.31B
EBITDA 1.42B
Net Income Avi to Common (ttm)823.4M
Diluted EPS (ttm)1.30
Quarterly Earnings Growth (yoy)10.50%

Balance Sheet

Total Cash (mrq)1.4B
Total Cash Per Share (mrq)2.25
Total Debt (mrq)694.9M
Total Debt/Equity (mrq)15.19
Current Ratio (mrq)3.46
Book Value Per Share (mrq)7.33

Cash Flow Statement

Operating Cash Flow (ttm)1.05B
Levered Free Cash Flow (ttm)373.75M